Shaff Eric D.
Seres Therapeutics, Inc. · Director
Shaff Eric D. is listed in filings as Director at Seres Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Seres Therapeutics, Inc. (MCRB). The current snapshot covers public activity from Aug 19, 2024 to May 19, 2026. Reported amounts are shown as $1.9K to $3.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.2k259 shares | SellFeb 15, 2026 | $8.47 | $7.58 | |
| $3.8k217 shares | SellNov 15, 2025 | $17.30 | $7.58 | |
| $3.6k217 shares | SellAug 18, 2025 | $16.65 | $7.58 | |
| $1.6k220 shares | SellMay 16, 2025 | $7.28 | $7.58 | |
| $10k12.7k shares | SellFeb 18, 2025 | $0.8105 | $7.58 | |
| $1.4k2.5k shares | SellNov 18, 2024 | $0.5409 | $7.58 | |
| $6.0k8.7k shares | SellOct 28, 2024 | $0.6901 | $7.58 | |
| $2.1k2.5k shares | SellAug 16, 2024 | $0.84 | $7.58 |